Musika wekambani, kushandiswa kwemabhiza nhasi
Stock quotes yekambani 71229 munguva chaiyo chaiye.
Musika wekambani, kushandiswa kwemabhiza nhasi

Stock quotes

Stock quotes online

Stock quotes history

Stock market capitalization

Stock Dividends

Kubatsira kubva kumakambani emakambani

Mishumo yemari

Rating share of companies. Ndekupi kwatingaisa mari?

Sierra Oncology, Inc. mutengo wemakesi

Nhamba yekutengeserana kwemabhizimisi Sierra Oncology, Inc. nhasi uye nhoroondo yemudzimai we Sierra Oncology, Inc. kubva pakutanga kwekutengeserana muSRRA mashizha mukutengesa.
Wedzera kune zvakasarudzwa
Yakawedzerwa kumajairika

Sierra Oncology, Inc. capitalization

Mazuva ano misika yemakemikari ye Sierra Oncology, Inc. is 1 342 939 392 US dhora.
+610 432 $ (+0.045%)
shanduko ye capitalization kubva zuro

Mazuva ese, tinonyora shanduko mu Sierra Oncology, Inc. capitalization. Sierra Oncology, Inc. capitalization nhasi inoonekwa sehuwandu hwehuwandu hwehuwandu hwekutengesa Sierra Oncology, Inc. mari yakapihwa. Sierra Oncology, Inc. capitalization yanhasi pawebsite yedu yekureva. Sierra Oncology, Inc., capitalization - 1 342 939 392 US madhora.

Sierra Oncology, Inc. ivhu rekutengeserana

Nhasi kutengeswa kwezvikamu zve Sierra Oncology, Inc. zvakave 297 500 US dhora.
-273 897 $ (-47.93%)
kuchinja kwehuwandu hwebhizimisi kubvira zuro

Nhasi, Sierra Oncology, Inc. kutengesa kwakaitika pamisika yakawanda yemasheya. Sierra Oncology, Inc. chati yekutengesa iri pane yedu webhusaiti zuva rega rega. Sierra Oncology, Inc. kutengeserana kwepamhepo kunoitwa pamisika yakawanda yemasheya, tinoratidza huwandu hwakazara hwe Sierra Oncology, Inc. kutengesa pazuva. Sierra Oncology, Inc. cap yemusika yakawedzera ne $ 610 432.

Ratidza:
Kuti

Sierra Oncology, Inc. musika wekodhi chati

Sierra Oncology, Inc. capitalization pagirazi nemakore. 0% pamwedzi - shanduko mumusika wemusika we Sierra Oncology, Inc.. Kwegore, Sierra Oncology, Inc. capitalization yashandurwa ne 0%. Nhasi, Sierra Oncology, Inc. capitalization inofungidzirwa ku 1 342 939 392 US madhora.

Vhiki Mwedzi 3 months Gore 3 years

Sierra Oncology, Inc. capital capital history

Zuva Capitalization
Capitalization (mutengo capital) ndiyo kukosha kwemusika wezvikamu zvose zvekambani zvakatengeswa pamutengo wekutengesa. Market capitalization yakaenzana nemutengo wezvikamu zvinowanikwa nenhamba yezvikamu zvakakosha.
30/06/2022 1 342 939 392 $
29/06/2022 1 342 328 960 $
28/06/2022 1 341 846 016 $
27/06/2022 1 341 846 016 $
24/06/2022 1 342 334 464 $
23/06/2022 1 341 846 016 $
22/06/2022 1 341 601 792 $

Sierra Oncology, Inc. vhidhiyo chati

Vhiki Mwedzi 3 months Gore 3 years

Sierra Oncology, Inc. nhoroondo yemota data

Zuva Bhuku (24h)
Nhamba yekutengeserana yeSierra Oncology, Inc. zvikamu ndeyewandu hwezvinhu zvose zvekutengeserana neSRRA zvikamu zvakatengwa uye zvinotengeswa panguva yakasarudzwa.
30/06/2022 297 500 $
29/06/2022 571 397 $
28/06/2022 105 122 $
27/06/2022 164 987 $
24/06/2022 94 224 $
23/06/2022 77 132 $
22/06/2022 250 291 $

On 30/06/2022, Sierra Oncology, Inc. misika yekutengesa yaive $ 1 342 939 392. 29/06/2022 Sierra Oncology, Inc. musika capitalization yakaenzana 1 342 328 960 US madhora. 28/06/2022 Sierra Oncology, Inc. musika capitalization yakaenzana 1 341 846 016 US madhora. Musika capitalization ye Sierra Oncology, Inc. at 27/06/2022 zvakaenzana 1 341 846 016 US madhora.

Sierra Oncology, Inc. musika capitalization uri $ 1 342 334 464 at 24/06/2022. Musika capitalization ye Sierra Oncology, Inc. yakanzi 1 341 846 016 US madhora pa 23/06/2022. Sierra Oncology, Inc. musika capitalization pa 22/06/2022 yakaenzana 1 341 601 792 US madhora.

Iko mari yepamusoro yeSierra Oncology, Inc. nhasi ndeye 1 342 939 392 $. Imari yepamusi yeSierra Oncology, Inc. yakachinja +0.045% inofananidzwa nezuro. Nhamba yekutengeserana ye SRRA nhengo dze Sierra Oncology, Inc. musi wekupedzisira wekutengesa yakava 297 500 $. Kutengeswa kwezvikamu zve Sierra Oncology, Inc. zvakachinjwa kusvika -47.935% zvichienzaniswa nezuva rekutanga rebhizimisi.

Mari yezvikamu Sierra Oncology, Inc.

Mari Sierra Oncology, Inc.